To compare the clinical efficacy and side effects of implant (JADELLE) and IUCD (COPPER T)
Keywords:
subdermal implant, JADELLE, intrauterine contraceptive device (IUCD), Copper-T contraceptiveAbstract
This study aims to compare the performance and side effects of the subdermal implant JADELLE and intrauterine contraceptive device Copper-T as long-acting reversible contraceptive methods. The study design involved a comparative analysis of Jadelle and Copper-T contraceptives, assessing clinical performance and side effects. Sample data from 336 participants was collected using stratified random sampling, with standardized instruments for demographic information, clinical assessment, and contraceptive side effects. Inclusion criteria were reproductive-age multipara women, while exclusion criteria included primary para, preexisting medical disorders, nullipara, and other contraceptive use. Ethical guidelines were followed, ensuring informed consent, privacy, and the right to withdraw. Statistical analysis employed descriptive statistics, chi-square test, independent samples t-test, and Kaplan-Meier survival analysis. SPSS (version 23.0) was used for analysis. The comparison between Group A (Jadelle) and Group B (Copper-T) reveals interesting findings. Group A has a higher mean age, but no significant differences in parity, blood pressure, or weight. Group B has more total and ongoing pregnancies. Group A experiences higher prevalence of side effects, including expulsion, infection, severe menstrual changes, pain or discomfort, and mood swings. Blood parameters show no significant differences. Variations exist in follow-up rates, informed consent, and privacy maintenance.
Downloads
References
Bahamondes, L., Brache, V., Meirik, O., Ali, M., Habib, N., Landoulsi, S., & WHO Study Group on Contraceptive Implants for Women (2015). A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls. Human reproduction (Oxford, England), 30(11), 2527–2538. https://doi.org/10.1093/humrep/dev221
Buasang, K., & Taneepanichskul, S. (2009). Efficacy of celecoxib on controlling irregular uterine bleeding secondary to Jadelle use. Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 92(3), 301–307.
Cirrincione, L. R., Nakalema, S., Chappell, C. A., Byakika-Kibwika, P., Kyohairwe, I., Winchester, L., Mackline, H., Pham, M. M., Cohn, S. E., Siccardi, M., Owen, A., Fletcher, C. V., Lamorde, M., & Scarsi, K. K. (2023). Effect of double-dose levonorgestrel subdermal implant in women taking efavirenz-based antiretroviral therapy: The DoubLNG pharmacokinetic study. Contraception, 122, 109975. https://doi.org/10.1016/j.contraception.2023.109975
Cleland J, Ali M, Benova L, Daniele M. The promotion of intrauterine contraception in low-and middle-income countries: a narrative review-NCND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 2017 [cited 2020 Jan 16]; https://doi.org/10.1016/j.contraception.2017.03.009
Daniele MAS, Cleland J, Benova L, Ali M. Provider and lay perspectives on intra-uterine contraception: a global review. Reprod Health. 2017 11.
Finer LB, Zolna MR. Declines in unintended pregnancy in the United States, 2008–2011. New England Journal of Medicine [Internet]. 2016 Mar 3 [cited 2022 Aug 20]; 374(9):843–52. Available from: https://www.nejm.org/doi/full/10.1056/nejmsa1506575
Gonzalo, I. T., Swerdloff, R. S., Nelson, A. L., Clevenger, B., Garcia, R., Berman, N., & Wang, C. (2002). Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone. The Journal of clinical endocrinology and metabolism, 87(8), 3562–3572. https://doi.org/10.1210/jcem.87.8.8710
Laphikanont, W., & Taneepanichskul, S. (2006). Effects of Jadelle used in Thai women aged between 20 and 45 years in King Chulalongkorn Memorial Hospital. Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 89(6), 761–766.
Moray, K. V., Chaurasia, H., Sachin, O., & Joshi, B. (2021). A systematic review on clinical effectiveness, side-effect profile and meta-analysis on continuation rate of etonogestrel contraceptive implant. Reproductive health, 18(1), 4. https://doi.org/10.1186/s12978-020-01054-y
NIPS. Pakistan Demographic and Health Survey [Internet]. Islamabad, Pakistan; Claverton, Maryland, USA; 2012 [cited 2017 Feb 5]. http://www. nips.org.pk/abstract_fles/PDHS Final Report as of Jan 22–2014.pdf
NIPS. Pakistan Demographic and Health Survey 2006–07 [Internet]. Islamabad, Pakistan; Claverton, Maryland, USA; 2006 [cited 2017 Feb 5]
NIPS. Pakistan Demographic and Health Survey 2017–18. 2017.
Tariq A etalLong-acting reversible contraceptives - Implant vs. Intrauterine Device; Why go for either? Long-acting reversible contraceptives Professional Med J 2023;30(01):51-57.
The World Health Organization (WHO) estimates that only one unintended pregnancy occurs among every 2000-implant users in the first year of use; the effectiveness of IUDs are nearly the same
UNDESA. Trends in contraceptive use Worldwide 2015. Contraception. 2015
Yu, J., Li, J., Li, H. G., Li, J. X., Xie, C. S., & Zhu, C. H. (2008). Comparative study on contraceptive efficacy and clinical performance of the copper/low-density polyethylene nanocomposite IUD and the copper T220C IUD. Contraception, 78(4), 319–323. https://doi.org/10.1016/j.contraception.2008.05.008
Published
How to Cite
Issue
Section
Copyright (c) 2023 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
